skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 46  for All Library Resources

Results 1 2 3 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Development of a Mechanism-Based Next-Generation Therapeutic for Heart Failure Derived From the Dark Genome
Material Type:
Article
Add to My Research

Development of a Mechanism-Based Next-Generation Therapeutic for Heart Failure Derived From the Dark Genome

JACC. Basic to translational science, 2023-12, Vol.8 (12), p.1595-1598 [Peer Reviewed Journal]

2023 The Authors. ;2023 The Authors 2023 ;ISSN: 2452-302X ;EISSN: 2452-302X ;DOI: 10.1016/j.jacbts.2023.09.006 ;PMID: 38205345

Full text available

2
AAV capsid engineering identified two novel variants with improved in vivo tropism for cardiomyocytes
Material Type:
Article
Add to My Research

AAV capsid engineering identified two novel variants with improved in vivo tropism for cardiomyocytes

Molecular therapy, 2022-12, Vol.30 (12), p.3601-3618 [Peer Reviewed Journal]

2022 The Author(s) ;Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved. ;2022 The Author(s) 2022 ;ISSN: 1525-0016 ;EISSN: 1525-0024 ;DOI: 10.1016/j.ymthe.2022.07.003 ;PMID: 35810332

Full text available

3
LNCRNAS FOR THERAPY AND DIAGNOSIS OF CARDIAC HYPERTROPHY
Material Type:
Patent
Add to My Research

LNCRNAS FOR THERAPY AND DIAGNOSIS OF CARDIAC HYPERTROPHY

Digital Resources/Online E-Resources

4
LNCRNAS FOR THERAPY AND DIAGNOSIS OF CARDIAC HYPERTROPHY
Material Type:
Patent
Add to My Research

LNCRNAS FOR THERAPY AND DIAGNOSIS OF CARDIAC HYPERTROPHY

Digital Resources/Online E-Resources

5
LncRNAs for therapy and diagnosis of cardiac hypertrophy
Material Type:
Patent
Add to My Research

LncRNAs for therapy and diagnosis of cardiac hypertrophy

Digital Resources/Online E-Resources

6
LNCRNAS FOR THERAPY AND DIAGNOSIS OF CARDIAC HYPERTROPHY
Material Type:
Patent
Add to My Research

LNCRNAS FOR THERAPY AND DIAGNOSIS OF CARDIAC HYPERTROPHY

Digital Resources/Online E-Resources

7
lncARNs para el tratamiento y el diagnóstico de la hipertrofia cardíaca
Material Type:
Patent
Add to My Research

lncARNs para el tratamiento y el diagnóstico de la hipertrofia cardíaca

Digital Resources/Online E-Resources

8
LNCRNAS FOR THERAPY AND DIAGNOSIS OF CARDIAC HYPERTROPHY
Material Type:
Patent
Add to My Research

LNCRNAS FOR THERAPY AND DIAGNOSIS OF CARDIAC HYPERTROPHY

Digital Resources/Online E-Resources

9
LNCRNAS til terapi og diagnose af hjertehypertrofi
Material Type:
Patent
Add to My Research

LNCRNAS til terapi og diagnose af hjertehypertrofi

Digital Resources/Online E-Resources

10
LNCRNAS FOR THERAPY AND DIAGNOSIS OF CARDIAC HYPERTROPHY
Material Type:
Patent
Add to My Research

LNCRNAS FOR THERAPY AND DIAGNOSIS OF CARDIAC HYPERTROPHY

Digital Resources/Online E-Resources

11
Abstract 114: Safety And Efficacy Of CDR132L, A Novel Antisense Therapeutic Which Targets MicroRNA-132 In Heart Failure Patients
Material Type:
Article
Add to My Research

Abstract 114: Safety And Efficacy Of CDR132L, A Novel Antisense Therapeutic Which Targets MicroRNA-132 In Heart Failure Patients

Circulation research, 2021-09, Vol.129 (Suppl_1) [Peer Reviewed Journal]

ISSN: 0009-7330 ;EISSN: 1524-4571 ;DOI: 10.1161/res.129.suppl_1.114

Full text available

12
ERBB4 and Multiple MicroRNAs That Target ERBB4 Participate in Pregnancy-Related Cardiomyopathy
Material Type:
Article
Add to My Research

ERBB4 and Multiple MicroRNAs That Target ERBB4 Participate in Pregnancy-Related Cardiomyopathy

Circulation. Heart failure, 2021-07, Vol.14 (7), p.e006898-e006898 [Peer Reviewed Journal]

ISSN: 1941-3289 ;EISSN: 1941-3297 ;DOI: 10.1161/CIRCHEARTFAILURE.120.006898 ;PMID: 34247489

Full text available

13
AntimiR-132 Attenuates Myocardial Hypertrophy in an Animal Model of Percutaneous Aortic Constriction
Material Type:
Article
Add to My Research

AntimiR-132 Attenuates Myocardial Hypertrophy in an Animal Model of Percutaneous Aortic Constriction

Journal of the American College of Cardiology, 2021-06, Vol.77 (23), p.2923-2935 [Peer Reviewed Journal]

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved. ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2021.04.028 ;PMID: 34112319

Full text available

14
CDR132L improves systolic and diastolic function in a large animal model of chronic heart failure
Material Type:
Article
Add to My Research

CDR132L improves systolic and diastolic function in a large animal model of chronic heart failure

European heart journal, 2021-01, Vol.42 (2), p.192-201 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. 2020 ;The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehaa791 ;PMID: 33089304

Full text available

15
Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study
Material Type:
Article
Add to My Research

Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study

European heart journal, 2021-01, Vol.42 (2), p.178-188 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. 2020 ;The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehaa898 ;PMID: 33245749

Full text available

16
Targeting muscle-enriched long non-coding RNA H19 reverses pathological cardiac hypertrophy
Material Type:
Article
Add to My Research

Targeting muscle-enriched long non-coding RNA H19 reverses pathological cardiac hypertrophy

European heart journal, 2020-09, Vol.41 (36), p.3462-3474 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. 2020 ;The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. ;The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. 2020 ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehaa519 ;PMID: 32657324

Full text available

17
The roles of miRNA, lncRNA and circRNA in the development of osteoporosis
Material Type:
Article
Add to My Research

The roles of miRNA, lncRNA and circRNA in the development of osteoporosis

Biological research, 2020-09, Vol.53 (1), p.1-40, Article 40 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;This work is licensed under a Creative Commons Attribution 4.0 International License. ;ISSN: 0717-6287 ;ISSN: 0716-9760 ;EISSN: 0717-6287 ;DOI: 10.1186/s40659-020-00309-z ;PMID: 32938500

Full text available

18
LNCRNAS FOR THERAPY AND DIAGNOSIS OF CARDIAC HYPERTROPHY
Material Type:
Patent
Add to My Research

LNCRNAS FOR THERAPY AND DIAGNOSIS OF CARDIAC HYPERTROPHY

Digital Resources/Online E-Resources

19
Preclinical development of a miR-132 inhibitor for heart failure treatment
Material Type:
Article
Add to My Research

Preclinical development of a miR-132 inhibitor for heart failure treatment

Nature communications, 2020-01, Vol.11 (1), p.633-10, Article 633 [Peer Reviewed Journal]

This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-020-14349-2 ;PMID: 32005803

Full text available

20
miR-21-KO Alleviates Alveolar Structural Remodeling and Inflammatory Signaling in Acute Lung Injury
Material Type:
Article
Add to My Research

miR-21-KO Alleviates Alveolar Structural Remodeling and Inflammatory Signaling in Acute Lung Injury

International journal of molecular sciences, 2020-01, Vol.21 (3), p.822 [Peer Reviewed Journal]

2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 by the authors. 2020 ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms21030822 ;PMID: 32012801

Full text available

Results 1 - 20 of 46  for All Library Resources

Results 1 2 3 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (19)

Refine My Results

Creation Date 

From To
  1. Before 2015  (3)
  2. 2015 To 2016  (5)
  3. 2017 To 2018  (10)
  4. 2019 To 2021  (20)
  5. After 2021  (9)
  6. More options open sub menu

Resource Type 

  1. Patents  (25)
  2. Articles  (19)
  3. Web Resources  (1)
  4. Book Chapters  (1)
  5. More options open sub menu

Language 

  1. English  (41)
  2. French  (8)
  3. Japanese  (6)
  4. German  (6)
  5. Polish  (2)
  6. Hungarian  (2)
  7. Danish  (2)
  8. Spanish  (2)
  9. Turkish  (1)
  10. Portuguese  (1)
  11. Chinese  (1)
  12. More options open sub menu

Searching Remote Databases, Please Wait